AC Immune SA (ACIU)

2.52 -0.14 (-5.26%) USD  |  NASDAQ  |  Sep 25, 16:00
2.51 -0.01 (-0.40%) After-Hours: 19:59
More

AC Immune Cash and Short Term Investments (Annual) : 115.38M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ACIU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2025 115.38M
December 31, 2024 182.61M
December 31, 2023 122.44M
December 31, 2022 132.50M
December 31, 2021 217.54M
December 31, 2020 255.55M
Date Value
December 31, 2019 298.02M
December 31, 2018 189.15M
December 31, 2017 127.63M
December 31, 2016 149.76M
December 31, 2015 76.45M
December 31, 2014 3.327M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Precigen, Inc. 97.86M
Basilea Pharmaceutica AG 204.91M
Santhera Pharmaceuticals Holding AG 28.32M
Aldeyra Therapeutics, Inc. 70.04M
BeOne Medicines Ltd. 4.589B